Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China
· Delayed Price · Currency is CNY 10.99
+0.01 (0.09%)
Apr 30, 2026, 3:00 PM CST
SHA:603998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,826 | 4,935 | 4,576 | 4,819 | 3,521 | 2,920 | Upgrade
|
| Market Cap Growth | 9.35% | 7.86% | -5.06% | 36.87% | 20.58% | 13.52% | Upgrade
|
| Enterprise Value | 5,078 | 5,328 | 5,188 | 5,463 | 3,898 | 3,469 | Upgrade
|
| Last Close Price | 10.99 | 11.10 | 9.90 | 10.18 | 7.23 | 5.90 | Upgrade
|
| PE Ratio | 15.70 | 16.11 | 17.93 | 25.80 | 12.32 | 41.69 | Upgrade
|
| Forward PE | 13.24 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | Upgrade
|
| PS Ratio | 2.69 | 2.83 | 2.57 | 2.96 | 1.97 | 1.86 | Upgrade
|
| PB Ratio | 2.63 | 2.74 | 2.64 | 3.03 | 2.34 | 2.24 | Upgrade
|
| P/TBV Ratio | 3.97 | 4.13 | 4.27 | 5.26 | 4.05 | 5.15 | Upgrade
|
| P/FCF Ratio | 14.37 | 17.49 | 45.69 | - | 27.01 | 3188.95 | Upgrade
|
| P/OCF Ratio | 10.90 | 12.83 | 23.47 | 55.06 | 11.67 | 15.73 | Upgrade
|
| EV/Sales Ratio | 2.84 | 3.05 | 2.92 | 3.35 | 2.17 | 2.21 | Upgrade
|
| EV/EBITDA Ratio | 11.98 | 13.24 | 16.20 | 23.24 | 17.43 | 18.18 | Upgrade
|
| EV/EBIT Ratio | 14.68 | 16.36 | 20.99 | 33.45 | 25.31 | 28.12 | Upgrade
|
| EV/FCF Ratio | 15.12 | 18.89 | 51.80 | - | 29.90 | 3788.09 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.24 | 0.40 | 0.43 | 0.39 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.96 | 1.07 | 2.17 | 2.87 | 2.56 | 2.74 | Upgrade
|
| Debt / FCF Ratio | 1.21 | 1.53 | 7.00 | - | 4.56 | 602.87 | Upgrade
|
| Net Debt / Equity Ratio | 0.08 | 0.09 | 0.23 | 0.28 | 0.10 | 0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.36 | 0.39 | 1.23 | 1.93 | 0.69 | 1.46 | Upgrade
|
| Net Debt / FCF Ratio | 0.45 | 0.55 | 3.92 | -3.45 | 1.18 | 303.32 | Upgrade
|
| Asset Turnover | 0.58 | 0.55 | 0.56 | 0.54 | 0.64 | 0.63 | Upgrade
|
| Inventory Turnover | 1.30 | 1.37 | 1.47 | 1.65 | 2.10 | 2.43 | Upgrade
|
| Quick Ratio | 0.50 | 0.50 | 0.49 | 0.38 | 0.80 | 0.45 | Upgrade
|
| Current Ratio | 0.91 | 0.88 | 0.88 | 0.74 | 1.19 | 0.69 | Upgrade
|
| Return on Equity (ROE) | 16.79% | 17.11% | 15.04% | 11.60% | 19.68% | 5.44% | Upgrade
|
| Return on Assets (ROA) | 6.97% | 6.44% | 4.87% | 3.40% | 3.42% | 3.12% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.80% | 13.66% | 10.36% | 7.79% | 8.04% | 6.40% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.90% | 17.10% | 12.60% | 8.90% | 8.00% | 8.50% | Upgrade
|
| Earnings Yield | 6.35% | 6.21% | 5.58% | 3.88% | 8.12% | 2.40% | Upgrade
|
| FCF Yield | 6.96% | 5.72% | 2.19% | -2.72% | 3.70% | 0.03% | Upgrade
|
| Dividend Yield | 2.28% | - | 2.53% | 2.85% | 4.84% | 2.54% | Upgrade
|
| Payout Ratio | 75.39% | 63.08% | 50.74% | 93.36% | 43.27% | 66.85% | Upgrade
|
| Buyback Yield / Dilution | 0.64% | 0.53% | 1.08% | -2.70% | 1.06% | -2.93% | Upgrade
|
| Total Shareholder Return | 2.95% | 0.53% | 3.60% | 0.15% | 5.90% | -0.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.